Clincosm LogoSign in Get a demo

lgmd2i

Showing 1 - 6 of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Long-Term Development of Muscular Dystrophy Outcome Assessments

Not yet recruiting
  • LGMD1A
  • +33 more
    • Richmond, Virginia
      Virginia Commonwealth University
    Aug 3, 2023

    Limb Girdle Muscular Dystrophy, Limb-Girdle Muscular Dystrophy Type 2, LGMD2I Trial (LION-101 dose level 1, LION-101 dose level

    Not yet recruiting
    • Limb Girdle Muscular Dystrophy
    • +8 more
    • LION-101 dose level 1
    • +2 more
    • (no location specified)
    Feb 17, 2022

    LGMD2I Trial in Richmond (BBP-418)

    Active, not recruiting
    • LGMD2I
    • Richmond, Virginia
      Virginia Commonwealth University
    Dec 17, 2021

    Patients With Limb-Girdle Muscular Dystrophy 2I

    Active, not recruiting
    • LGMD2I
      • Copenhagen, Denmark
      • +2 more
      Jan 4, 2022

      LGMD2I Trial in Baltimore (PF 06252616)

      Completed
      Has Results
      • LGMD2I
      • PF 06252616
      • Baltimore, Maryland
        Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
      Sep 23, 2020

      LGMD2I, LGMDR9, Limb Girdle Muscular Dystrophy Trial in Newcastle upon-Tyne (Patient Registry)

      Unknown status
      • LGMD2I
      • +6 more
      • Patient Registry
      • Newcastle upon-Tyne, United Kingdom
        The John Walton Muscular Dystrophy Research Centre
      Oct 5, 2020